Dr. Daniela Vergara, The upstream genes in the cannabinoid biochemical pathway

February 2023

Dr. Daniela Vergara is an evolutionary biologist, data analyst, educator, scientific writer, and public speaker. In addition to her multiple publications, she founded and directs a non-profit organization, the Agricultural Genomics Foundation (AGF; AgriculturalGenomics.org). AGF aims to make hemp and cannabinoid science available to a broad public. Vergara has been part of escientific teams at private companies including Steep Hill, Inc. who are a global leader in agricultural testing, and the biotech company Front Range Biosciences. Dr. Vergara recently joined the Harvest New York Extension Team from Cornell University as an ‘Emerging Crop Specialist’ to help hemp farmers with their crop.

Dr. Vergara’s scientific publications include the comparison of the cannabinoids by the federally produced Cannabis to that produced by the private market. These results were featured in news platforms such as The Atlantic, Science, and FiveThirtyEight. Recently, she published a comparison between the genome of these federally produced varieties to the genome of the varieties found in the private markets. Some of her other scientific publications are a compilation of the existing genomic tools available for Cannabis research that was featured in Science, and the maternally inherited genomes (chloroplast and mitochondria). Vergara has authored these publications along with collaborators from the private sector in the Cannabis industry as well as academics from several institutions worldwide.

Vergara is also an international consultant and policy advisor and has advised companies in the US and Latin America. Additionally, she has worked as an expert witness for multiple legal cases in the US and abroad. Dr. Vergara is a scientific writer in both Spanish and English and has translated her scientific work in Spanish for a broad public in Hispanic Countries.

Previous Webinars

Margaret Haney, PhD

Nov 13, 2025 01:00 PM MST

Cannabis Misuse and Therapeutic Potential: Placebo-controlled Laboratory Studies

Dr. Margaret (Meg) Haney is a Professor of Neurobiology (in Psychiatry) at the Columbia University Irving Medical Center. As the Director of the Cannabis Research Laboratory and of the Substance Use Research Center in the Division of Substance Use Disorders, Dr. Haney is […]

Read More »

Dan Ovadya, CEO

New Methods for Induction of Male Flowers and Scalable Feminized Seed Production in Cannabis Sativa

Dan Ovadya is the Co-founder and CEO of FloraGen LLC, an AgTech company based in Davis, California. Dan has
over 30 years of experience in crop optimization, precision horticulture and seed production systems in controlled
environments. His career in Ag-Biotech centered on developing […]

Read More »

Marguerite Bolt, MS

Sep 17, 2025 11:00 AM MST

Bugs on Buds Pest Management in Cannabis

Marguerite Bolt is the Hemp Extension Specialist in the Department of Agronomy. Marguerite received her M.S. in Entomology from Purdue University, and her B.S. in Entomology from Michigan State University. She has aided in the development of pest management resources for hemp growers in […]

Read More »

Mark T. Hamann, PhD.

September 11, 2025 01:00 PM MST

Potential Application of the Cannabinoids as Antivirals

Dr. Mark T. Hamann is the Charles and Carol Cooper/SmartState Endowed Chair of Drug Discovery at the Medical University of South Carolina (MUSC), serving in the Colleges of Pharmacy and Medicine. He holds affiliate appointments with the University of Maryland’s Institute of Marine and […]

Read More »

Todd P. Michael, Ph.D.

20 August 2025, 11 AM MST

The Cannabis pangenome

Todd Michael, Ph.D. is a Research Professor at the Salk Institute for Biological Studies, an Adjunct Professor at the University of California, San Diego (UCSD), and Chief Science Officer at the San Diego Botanic Garden (SDBG). His research group focuses on leveraging advanced sequencing technologies and informatics to […]

Read More »